REGN CapEx to Revenue

Regeneron Pharmaceuticals · CapEx to Revenue

REGN logo

REGN CapEx to Revenue

Current (TTM)5.93%
REGN CapEx/Revenue (0.00% → 5.93%)
High-resolution chart · PNG

REGN capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
6.2637%
5.3225%
7.0625%
4.8477%
3.434%
7.2331%
6.5512%
5.7087%
4.6422%
10.532%
16.5199%
11.8106%
7.4272%
3.5791%
12.834%
21.7152%
25.6594%
14.6177%
14.754%
4.4305%
7.4993%
3.5479%
51.5783%
156.3125%
37.4232%
10.9572%
16.5217%
7.8534%
6.3444%
35.6846%
12.0438%
29.7414%
96.2264%
18.2609%
13.6986%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.